NASDAQ: ACB
Aurora Cannabis Inc. is a vertically integrated cannabis company focused on medical cannabis. Its operations span cultivation, manufacturing, packaging and distribution, supported by research and development, genetics and breeding, and patient counselling services.
The company has three main lines of activity:
- **Canada:** produces, distributes and sells medical cannabis under the Cannabis Act. Its Canadian consumer cannabis channel is being wound down.
- **European Union:** produces and distributes wholesale medical cannabis under German medicinal and narcotics laws, including from its Leuna, Germany facility.
- **Other international markets:** distributes wholesale medical cannabis, including in Australia, New Zealand, Poland and the United Kingdom.
It reports one operating segment, Cannabis. Sales channels are Canadian medical, international medical, Canadian consumer and wholesale bulk. International medical sales, led by Germany and Poland, are now the largest revenue driver.
Cultivation facilities include Alpine in Pemberton, British Columbia, River in Markham, Ontario, and Leuna in Germany.
In fiscal 2027 Aurora made two acquisitions:
- Safari Flower Company, adding EU-GMP certified cultivation capacity.
- UK-based Internode Pharma (importer/wholesaler) and HAP Pharma (pharmacy), giving it control of UK distribution.
It divested its 50.1% interest in Bevo Agtech, a plant propagation business, in February 2026. Its shares trade on Nasdaq and the TSX under 'ACB' and on the Frankfurt Stock Exchange.
In November 2026 Aurora agreed to be acquired by Organigram Global Inc., after its board recommended rejecting an unsolicited bid from Curaleaf. Updated
A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company’s following moved the wrong way. Tilray Brands shares are at $3.56, down…
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to Schedule…
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation…
The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like…
It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector, envisioning a booming…
From Hype to Hiccups in the Cannabis Craze Once hailed as the “next big thing,” cannabis stocks in 2018-2019 were the artificial intelligence stock darlings of their day, riding a wave of…
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug.
Thursday's top analyst upgrades and downgrades included ADT, Aurora Cannabis, CarMax, Shift4 Payments, Skechers USA, Tesla and Tilray.
After U.S. markets close Thursday, Aurora Cannabis and Toast will report quarterly results. Here's what to look for.
President Biden on Thursday pardoned people who had been convicted of federal charges of simple possession of marijuana, sending pot stocks soaring. But strong headwinds remain for the industry.
Wednesday's additional top analyst upgrades and downgrades were on Aurora Cannabis, Block, Cisco Systems, Datadog, Micron Technology, Stitch Fix and more.
Here is what analysts expect when these three companies post their quarterly results late Tuesday or first thing Wednesday morning.
Friday's additional top analyst upgrades and downgrades included Altria, Aurora Cannabis, Baxter International, Marathon Oil, Progressive and Shopify.
Monday’s additional top analyst upgrades and downgrades were on American Express, Aurora Cannabis, Edison International, Eli Lilly, PayPal, Upwork and more.
Aurora Cannabis Inc. is a vertically integrated cannabis company focused on medical cannabis. Its operations span cultivation, manufacturing, packaging and distribution, supported by research and development, genetics and breeding, and patient counselling services.
